fbpx

Woman Awarded $70M After Contracting Cancer From Johnson & Johnson Talcum Powder

Woman Awarded $70M After Contracting Cancer From Johnson & Johnson Talcum Powder

Natural News

David Gutierrez

November 2, 2016

“Alexandra Scranton, director of science and research at Women’s Voices for the Earth, has characterized Johnson and Johnson’s behavior as typical of Big Pharma and other companies that go to extreme lengths to keep selling products even as evidence mounts of their dangers.

Scranton said that documents uncovered during the Fox trial show that for decades, Johnson & Johnson sought to take advantage of the scientific uncertainty over the talc-ovarian cancer link, downplaying the potential risk rather than pursing a “clearly more ethical role, to take a precautionary approach.” Indeed, Scranton notes, the company “poured money over years into defending talc.”

Read More

Leave a Reply

Show Buttons
Hide Buttons